Hb H disease: clinical course and disease modifiers.

doi:10.1182/asheducation-2009.1.26

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Hb H disease: clinical course and disease modifiers.

Hematology. American Society of Hematology. Education Program - 1 Jan 2009

Fucharoen Suthat, Viprakasit Vip

Abstract excerpt

Hemoglobin H (Hb H) disease is the most common form of thalassemia intermedia and has many features that require careful consideration in management. In the majority of cases, Hb H disease results from double heterozygosity for alpha(0)-thalassemia due to deletions that remove both linked alpha-globin genes on chromosome 16, and deletional alpha(+)-thalassemia from single alpha-globin gene deletions (--/-alpha)....

Topics

Folic Acid
Genetic Heterogeneity
Hemoglobins, Abnormal
Humans
Infant, Newborn
Phenotype
Sequence Deletion
Splenectomy
alpha-Globins
alpha-Thalassemia

Source

Open in PubMed

Identifiers

PMID: 20008179
DOI: 10.1182/asheducation-2009.1.26

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics